Expanded Access Program for Radium-223 in Prostate Cancer

Oliver Sartor, MD

Oliver Sartor, MD, medical director, Tulane Cancer Center, discusses the United States experience of the Expanded Access Program (EAP) on radium-223 for prostate cancer.